← BACK TO SEARCH RESULTS
Rohit Singh, MD
Assistant Professor
Assistant Professor, Division of Hematology & Oncology
Population Sciences and Cancer Outcomes (PSCO)
Graduate Students in LabInterested in MentoringAccepting Summer Students
Key Areas of Interest / Study
Cancer disparities, Cancer immunology, Cancer immunotherapy, Health services research, Implementation and dissemination science, Lung cancer, Melanoma/sarcoma, Quality-based research, Survivorship/supportive care
Academic Interests
I am a medical oncologist specializing in the care of patients with lung cancer, melanoma, and other skin cancers. My research focuses on improving how cancer treatments, particularly immunotherapy are delivered in real-world practice, with an emphasis on reducing treatment-related symptoms and improving quality of life.
I lead and participate in clinical trials and investigator-initiated studies that explore new ways to optimize immunotherapy, including studies focused on fatigue management and treatment timing. I also collaborate on outcomes and health services research to better understand disparities in cancer care and to improve supportive and palliative care integration.
I lead and participate in clinical trials and investigator-initiated studies that explore new ways to optimize immunotherapy, including studies focused on fatigue management and treatment timing. I also collaborate on outcomes and health services research to better understand disparities in cancer care and to improve supportive and palliative care integration.
Awards, Honors, and Appointments
JCO editorial fellowship, served as an editorial fellow for the JCO journal. Later served as a editorial mentor for multiple physicians across the world (2023- 2025)
- ASCO Trainee & Early Career Advisory Group
- Served as an editorial mentor for multiple physicians across the world for the JCO journal (2024- 2025)
- ASCO Trainee & Early Career Advisory Group
- Served as an editorial mentor for multiple physicians across the world for the JCO journal (2024- 2025)

